Evidence map›Paper›PMID 38097644›Full record

ArticleScientific reports2023

Structure and functional impact of glycosaminoglycan modification of HSulf-2 endosulfatase revealed by atomic force microscopy and mass spectrometry.

Ilham Seffouh, Mélanie Bilong, Cédric Przybylski, Nesrine El Omrani, Salomé Poyer, Guillaume Lamour, Marie-Jeanne Clément, Rebecca-Joe Boustany, Evelyne Gout, Florence Gonnet and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Ilham Seffouh *Université Paris-Saclay, Univ Evry, CY Cergy Paris Université, CNRS, LAMBE, 91025, Evry-Courcouronnes, France.
Mélanie Bilong *Université Paris-Saclay, Univ Evry, CY Cergy Paris Université, CNRS, LAMBE, 91025, Evry-Courcouronnes, France.
Cédric PrzybylskiUniversité Paris-Saclay, Univ Evry, CY Cergy Paris Université, CNRS, LAMBE, 91025, Evry-Courcouronnes, France.
Nesrine El OmraniUniversité Paris-Saclay, Univ Evry, CY Cergy Paris Université, CNRS, LAMBE, 91025, Evry-Courcouronnes, France.
Salomé PoyerUniversité Paris-Saclay, Univ Evry, CY Cergy Paris Université, CNRS, LAMBE, 91025, Evry-Courcouronnes, France.
Guillaume LamourUniversité Paris-Saclay, Univ Evry, CY Cergy Paris Université, CNRS, LAMBE, 91025, Evry-Courcouronnes, France.
Marie-Jeanne ClémentUniversité Paris-Saclay, Univ Evry, INSERM, SABNP, 91025, Evry-Courcouronnes, France.
Rebecca-Joe BoustanyUniv. Grenoble Alpes, CNRS, CEA, IBS, Grenoble, France.
Evelyne GoutUniv. Grenoble Alpes, CNRS, CEA, IBS, Grenoble, France.
Florence GonnetUniversité Paris-Saclay, Univ Evry, CY Cergy Paris Université, CNRS, LAMBE, 91025, Evry-Courcouronnes, France.
Romain R VivèsUniv. Grenoble Alpes, CNRS, CEA, IBS, Grenoble, France.
Régis DanielUniversité Paris-Saclay, Univ Evry, CY Cergy Paris Université, CNRS, LAMBE, 91025, Evry-Courcouronnes, France. regis.daniel@univ-evry.fr.
Centre National de la Recherche Scientifique · FRLaboratoire Analyse et Modélisation pour la Biologie et l'Environnement · FRUniversité Paris-Saclay · FRCEA Grenoble · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRUniversité d'Évry Val-d'Essonne · FRUniversité Grenoble Alpes · FR

Funding

Agence Nationale de la Recherche ANR-15-IDEX-02Agence Nationale de la Recherche ANR-17-CE11-040
6 · The paper itself

Abstract

The human sulfatase HSulf-2 is one of only two known endosulfatases that play a decisive role in modulating the binding properties of heparan sulfate proteoglycans on the cell surface and in the extracellular matrix. Recently, HSulf-2 was shown to exhibit an unusual post-translational modification consisting of a sulfated glycosaminoglycan chain. This study describes the structural characterization of this glycosaminoglycan (GAG) and provides new data on its impact on the catalytic properties of HSulf-2. The unrevealed nature of this GAG chain is identified as a chondroitin/dermatan sulfate (CS/DS) mixed chain, as shown by mass spectrometry combined with NMR analysis. It consists primarily of 6-O and 4-O monosulfated disaccharide units, with a slight predominance of the 4-O-sulfation. Using atomic force microscopy, we show that this unique post-translational modification dramatically impacts the enzyme hydrodynamic volume. We identified human hyaluronidase-4 as a secreted hydrolase that can digest HSulf-2 GAG chain. We also showed that HSulf-2 is able to efficiently 6-O-desulfate antithrombin III binding pentasaccharide motif, and that this activity was enhanced upon removal of the GAG chain. Finally, we identified five N-glycosylation sites on the protein and showed that, although required, reduced N-glycosylation profiles were sufficient to sustain HSulf-2 integrity.

Indexed as

GlycosaminoglycansSulfatasesChondroitin SulfatesHeparan Sulfate ProteoglycansHumansMass SpectrometryMicroscopy, Atomic ForceChondroitin SulfatesGlycosaminoglycansHeparan Sulfate ProteoglycansSulfatases

Identifiers

PMID38097644
PMCPMC10721642
OpenAlexW4389724984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.